Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Thyroid Neoplasms 1Psoriasis Vulgaris 1Pelvic Neoplasms 1Mucositis 1Malnutrition 1Infections 1Gastrointestinal Neoplasms 1Fibrosis 1Enteritis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Cancer Therapy-related Cardiovascular Toxicity 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Pentoxifylline 2Blood Specimen Collection 2contrast agent BR1 1alpha-Tocopherol 1Tocopherols 1Spermine Synthase 1Sonazoid 1Propofol 1Probiotics 1N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide 1Mass Screening 1Iodides 1Hyperbaric Oxygenation 1Hematologic Tests 1Gemcitabine 1Diet, Mediterranean 1Dexmedetomidine 1Clinical Protocols 1BCG Vaccine 1Arthroplasty, Replacement, Knee 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Fibrosis × Probiotics × Clear all
NCT03853928 2019-02-27

Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis

Austral University, Argentina

Phase NA Unknown
280 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡